Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi (IST:BANVT)
158.60
-3.40 (-2.10%)
At close: Apr 28, 2026
IST:BANVT Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 33,492 | 41,275 | 30,789 | 20,274 | 5,321 | Upgrade
|
| Revenue Growth (YoY) | -18.86% | 34.06% | 51.86% | 280.98% | 44.69% | Upgrade
|
| Cost of Revenue | 32,644 | 31,750 | 27,223 | 20,837 | 4,652 | Upgrade
|
| Gross Profit | 847.97 | 9,525 | 3,566 | -563.25 | 669.88 | Upgrade
|
| Selling, General & Admin | 3,594 | 4,005 | 2,379 | 1,585 | 373.58 | Upgrade
|
| Research & Development | 0.72 | 1.16 | 0.62 | 0.34 | 3.15 | Upgrade
|
| Other Operating Expenses | 348.44 | -878.84 | -1,135 | -168.86 | -4.73 | Upgrade
|
| Operating Expenses | 3,943 | 3,127 | 1,245 | 1,417 | 372 | Upgrade
|
| Operating Income | -3,095 | 6,398 | 2,321 | -1,980 | 297.87 | Upgrade
|
| Interest Expense | -894.56 | -1,022 | -878.29 | -424.78 | -193.48 | Upgrade
|
| Interest & Investment Income | 2,092 | 1,339 | 192.84 | 104.25 | 220.44 | Upgrade
|
| Currency Exchange Gain (Loss) | -269.74 | -409.4 | -2,137 | -576.34 | -167.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -739.78 | 334.78 | 2,535 | 1,939 | -13.85 | Upgrade
|
| EBT Excluding Unusual Items | -2,906 | 6,640 | 2,034 | -937.65 | 143.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -25.78 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 96.34 | - | - | - | Upgrade
|
| Pretax Income | -2,906 | 6,736 | 2,034 | -937.65 | 118.29 | Upgrade
|
| Income Tax Expense | 208.8 | 2,025 | 587.9 | 14.41 | 23.14 | Upgrade
|
| Earnings From Continuing Operations | -3,115 | 4,711 | 1,446 | -952.06 | 95.15 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -71.26 | -30.61 | - | Upgrade
|
| Net Income | -3,115 | 4,711 | 1,374 | -982.67 | 95.15 | Upgrade
|
| Net Income to Common | -3,115 | 4,711 | 1,374 | -982.67 | 95.15 | Upgrade
|
| Net Income Growth | - | 242.75% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 100 | 100 | 100 | 100 | 100 | Upgrade
|
| Shares Outstanding (Diluted) | 100 | 100 | 100 | 100 | 100 | Upgrade
|
| EPS (Basic) | -31.14 | 47.10 | 13.74 | -9.82 | 0.95 | Upgrade
|
| EPS (Diluted) | -31.14 | 47.10 | 13.74 | -9.82 | 0.95 | Upgrade
|
| EPS Growth | - | 242.75% | - | - | - | Upgrade
|
| Free Cash Flow | -23,409 | -16,463 | -15,812 | -14,440 | -3,450 | Upgrade
|
| Free Cash Flow Per Share | -234.04 | -164.60 | -158.09 | -144.37 | -34.49 | Upgrade
|
| Gross Margin | 2.53% | 23.08% | 11.58% | -2.78% | 12.59% | Upgrade
|
| Operating Margin | -9.24% | 15.50% | 7.54% | -9.77% | 5.60% | Upgrade
|
| Profit Margin | -9.30% | 11.41% | 4.46% | -4.85% | 1.79% | Upgrade
|
| Free Cash Flow Margin | -69.89% | -39.89% | -51.36% | -71.23% | -64.83% | Upgrade
|
| EBITDA | -1,353 | 8,290 | 4,013 | -1,261 | 525.22 | Upgrade
|
| EBITDA Margin | -4.04% | 20.08% | 13.03% | -6.22% | 9.87% | Upgrade
|
| D&A For EBITDA | 1,741 | 1,892 | 1,692 | 719.22 | 227.35 | Upgrade
|
| EBIT | -3,095 | 6,398 | 2,321 | -1,980 | 297.87 | Upgrade
|
| EBIT Margin | -9.24% | 15.50% | 7.54% | -9.77% | 5.60% | Upgrade
|
| Effective Tax Rate | - | 30.06% | 28.91% | - | 19.56% | Upgrade
|
| Advertising Expenses | 86.01 | 98.32 | 43.73 | 54.27 | 21.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.